This is to inform you that the Board of Directors of the Company at their meeting held today i.e. 19/06/2025 have approved to incorporate a wholly-owned subsidiary Company in Canada.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sudarshan Pharma Industries Ltd's Board of Directors, at a meeting held on 19 June 2025, approved the incorporation of a wholly-owned subsidiary company in Canada. The new entity will operate in the manufacturing of chemical and pharmaceutical products, as well as trading in general and FMCG goods, with the goal of establishing a business presence in the North American market. The company will hold 100% stake in the proposed subsidiary. The incorporation is expected to be completed within 6 months and will require RBI approval under the automatic route under the Foreign Exchange Management (Overseas Investment) Rules. The transaction is not a related party transaction, and no cash consideration or share swap is involved since it is a fresh incorporation.
This is an early-stage expansion move into the Canadian/North American market. It signals management's intent to grow internationally, but since the subsidiary is still to be incorporated and no financials have been disclosed yet, there is no immediate material impact on shareholders. Investors should watch for further updates on timelines and capital deployment.